Clinical Trial

Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

Recruiting
View on ClinicalTrials.gov →
Summary
Neonatal salt loss can be caused not only by infections but also by rare endocrine disorders that resemble 21-hydroxylase deficiency but are not detected by neonatal screening. This study examines how often these conditions occur and describes their main clinical, genetic, and treatment features.
Trial Details
NCT Number NCT07473804
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Neonatal Salt Loss, Congenital Adrenal Hyperplasia (CAH)
Enrollment 25 participants
Start Date 2025-04-14
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-16